Hepatobiliary surgery

Journal of Hepatology

Volumn 32, Issue SUPPL.1, 2000, Pages 208-224

  Bismuth, Henri ^b   Majno, Pietro E ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

Cholangiocarcinoma; Hepatocellular carcinoma; Liver resection; Liver surgery; Metastasis

Indexed keywords

FLUOROURACIL; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; TEGAFUR;

ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; BILE DUCT INJURY; BILIARY TRACT SURGERY; CATHETER ABLATION; CHOLECYSTECTOMY; CHOLELITHIASIS; CRYOTHERAPY; GALLBLADDER CANCER; GENE THERAPY; HUMAN; LAPAROSCOPIC SURGERY; LIVER REGENERATION; LIVER SURGERY; LIVER TRANSPLANTATION; LIVING DONOR; PORTAL VEIN; PRIORITY JOURNAL; RADIOFREQUENCY; REVIEW;

BILE DUCT NEOPLASMS; BILE DUCTS; BILIARY TRACT SURGICAL PROCEDURES; CHOLELITHIASIS; GALLBLADDER NEOPLASMS; HUMANS; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION;

EID: 0034090716     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80427-4     Document Type: Article

References (169)

1. Neugebauer E, Troidl H, Kum CK, Eypasch E, Miserez M, Paul A. The E.A.E.S. Consensus Development Conferences on laparoscopic cholecystectomy, appendectomy, and hernia repair. Consensus statements-September 1994. The Educational Committee of the European Association for Endoscopic Surgery. Surg Endosc 1995; 9: 550-63.
2. Barkun JS, Barkun AN, Sampalis JS, Fried G, Taylor B, Wexler MJ, et al. Randomised controlled trial of laparoscopic versus mini cholecystectomy. The McGill Gallstone Treatment Group. Lancet 1992; 340: 1116-9.
3. Berggren U, Gordh T, Grama D, Haglund U, Rashad J, Arvidsson D. Laparoscopic versus open cholecystectomy: hospitalization, sick leave, analgesia, and trauma responses. Br J Surg 1994; 81: 1362-5.
4. McMahon AJ, Russell IT, Baxter JN, Ross S, Anderson JR, Morran CG, et al. Laparoscopic versus minilaparotomy cholecystectomy: a randomised trial. Lancet 1994; 343: 135-8.
5. Steiner CA, Bass EB, Talamini MA, Pitt HA, Steinberg E. Surgical rates and operative mortality for open and laparoscopic cholecystectomy in Maryland. N Engl J Med 1994; 330: 403-8.
6. Shea JA, Healey MJ, Berlin JA, Clarke JR, Malet PF, Staroscik RN, et al. Mortality and complications associated with laparoscopic cholecystectomy. A meta-analysis. Ann Surg 1996; 224: 609-20.
7. Strasberg SM, Herl M, Soper NJ. An analysis of the problem of biliary injury during laparoscopic cholecystectomy. J Am Coll Surg 1995; 180: 101-25.
8. Adamsen S, Hansen OH, Fuch-Jensen P, Schulze S, Stage G, Wara P. Bile duct injury during laparoscopic cholecystectomy: a prospective nationwide series. J Am Coll Surg 1997; 184: 571-8.
9. Russel JC, Walsh SJ, Mattie AS, Lynch LT X. Bile duct injuries, 1989-1993: a statewide experience. Arch Surg 1996; 131: 382-7.
10. Gigot J, Etienne J, Aerts R, Wibin E, Dallemagne B, Deweer F, et al. The dramatic reality of biliary tract injury during laparoscopic cholecystectomy. An anonymous multicenter Belgian survey of 65 patients. Surg Endosc 1997; 11: 1171-8.
11. Bismuth H, Majno PE. Bile duct injuries: Classification and principles for surgical treatment. World J Surg, in press.
12. Schwesinger WH, Diehl AK. Changing indications for laparoscopic cholecystectomy. Stones without symptoms and symptoms without stones. Surg Clin North Am 1996; 76: 493-504.
13. Abboud PA, Malet PF, Berlin JA, Staroscik R, Cabana MD, Clarke JR, et al. Predictors of common bile duct stones prior to cholecystectomy: a meta-analysis. Gastrointest Endosc 1996: 44: 450-9.
14. Prat F, Meduri B, Ducot B, Chiche R, Salimbeni-Bartolini R, Pelletier G. Prediction of common bile duct stones by non-invasive tests. Ann Surg 1999; 229: 362-8.
15. Cotton PB. Endoscopic retrograde cholangiopancreatography and laparoscopic cholecystectomy. Am J Surg 1993; 165: 474-8.
16. Reding R, Buard JL, Lebeau G, Launois B. Surgical management of 522 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumours excluded): results of the French surgical association survey. Ann Surg 1991; 213: 236-41.
17. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 1990; 14: 535-44.
18. Bismuth H, Nackache, Diamond T Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215: 31-8.
19. Ogura Y, Mizumoto R, Tabata M, Matsuda S, Kusuda T. Surgical treatment of carcinoma of the hepatic duct confluence: analyisis of 55 resected carcinomas World J Surg 1993; 17: 85-93.
20. Tashiro S, Tsuji T, Kanenemitsu K, Kamimoto Y, Hiraoka T, Miyauchi Y. Prolongation of survival for carcinoma at the hepatic duct confluence. Surgery 1993; 113: 270-8.
21. Gazzaniga GM, Flauro M, Bagarolo C, Ciferri E, Bondanza G. Neoplasm of the hepatic hilum: the role of resection. Hepato Gastroenterol 1993; 40: 244 8.
22. Nagorney DM, Donohue GH, Farnell MB, Schleck CD, Ilstrup LS. Outcomes after curative resection for cholangiocarcinoma. Arch Surg 1993; 128: 871-9.
23. Sugiura Y, Nakamura S, Iida S. Extensive resection of bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio bile duct cancer study group. Surgery 1994; 115: 445-51.
24. Washburn KW, Lewis D, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 1995; 130: 270-6.
25. Miyagawa S, Makuuchi M, Kawasaki S. Outcome of extended right hepatectomy after biliary drainage in hilar bile duct cancer. Arch Surg 1995; 130: 759-63.
26. Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Maschek H, Tusch G, et al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996; 224: 628-38.
27. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M, Kanai M. Hepatectomy for bile duct cancer. Asian J Surg 1996; 19: 94-100.
28. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar and distal tumors. Ann Surg 1996; 224: 463-75.
29. Su CH, Tsay SH, Wu CC, Shyr YM, King KL, Lee CH, et al. Factors influencing postoperative morbidity, mortality and survival after resection for hilar cholangiocarcinoma. Ann Surg 1996; 223: 384-94.
30. Barish MA, Yucel KE, Ferrucci JT. Magnetic resonance cholangiopancreatography. N Engl J Med 1999; 341: 258-64.
31. Nimura Y. Staging of biliary carcinoma: cholangiography and cholangioscopy. Endoscopy 1993; 25: 76-80.
32. Tamada K, Ino K Ueno N, Kimura K, Ichiyama M, Tomiyama T. Preoperative staging of extrahepatic bile duct cancer with intraductal ultrasonography. Am J Gastroenterol 1995; 90: 239-46.
33. Majno PE, Azoulay D, Bismuth H. Malignant biliary obstruction. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodés J, editors. Oxford Textbook of Clinical Hepatology, 2nd edn. Oxford: Oxford University Press; 1999. p. 1997-2008.
34. Cubertafond P, Mathonnet M, Gainant A, Launois. Radical surgery for gallbladder cancer. Results of the French Surgical Association Survey. J Hepatogastroenterol 1999; 46: 1567-71.
35. Shirai Y, Yoshida K, Tsukada K, Muto T. Inapparent carcinoma of the gallbladder. Ann Surg 1992; 215: 326-31.
36. Chijiiwa K, Tanaka. Carcinoma of the gallbladder: an appraisal of surgical resection. Surgery 1994; 115: 751-6.
37. Onoyama H, Yamamoto M, Tseng A, Ajiki T, Saitoh Y. Extended cholecystectomy for carcinoma of the gallbladder. World J Surg 1995; 19: 758-63.
38. Bloechle C, Izbicki JR, Passlick B, Gawad K, Passow C, Rogiers X, et al. Is radical surgery in locally advanced gallbladder carcinoma justified? Am J Gastroenterol 1994; 91: 2195-200.
39. Tsukada K, Hatakeyama K, Kurosaki I, Uchida K, Shirai Y, Muto T, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery 1996; 120: 816-22.
40. Bartlett DL, Fong Y, Fortner J, Brennan MF, Blumgart LH. Long term results after resection for gallbladder cancer. Ann Surg 1996; 224: 639-46.
41. Cavina E, Goletti O, Molea N, Buccianti P, Chiarugi M, Boni G, et al. Trocar site tumor recurrences. May pneumoperitoneum be responsible? Surg Endosc 1998; 12: 1294-6.
42. Couinaud C. Le foie: Etudes anatomiques et chirurgicales. Paris: Masson; 1957. p. 13-33.
43. Bismuth H.Anatomical surgery and surgical anatomy of the liver. World J Surg 1982; 6: 3-9.
44. Takayama T, Makuuchi M, Watanabe K, Kosuge T, Takayasu K, Yamazaki S, et al. A new method for mapping hepatic subsegment : counterstaining identification technique. Surgery 1991; 109: 226-9.
45. Makuuchi M, Hasagawa H, Yamazaki S Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1987; 164: 69-72.
46. Igawa S, Sakai K, Kinoshita H, Hirohashi K Intra-operative sonography: Clinical usefulness in liver surgery. Radiology 1985; 156: 473-8.
47. Scheele J, Stangl R. Segment orientated anatomical resections. In: Blumgart LH, editor. Surgery of the liver and biliary tract, 2nd edn. Edinburgh: Churchill - Livingstone; 1994. p. 1557-78.
48. Bismuth H, Fecteau A. Hepatobiliary surgery. In: Bacon DR, DiBisceglie AM, editors. Liver Disease. Edinburgh: Churchill-Livingstone; 1999 (in press).
49. Marescaux J, Clement JM, Tassetti V, Koehl C, Cotin S, Russier Y, et al. Virtual reality applied to hepatic surgery simulation: the next revolution. Ann Surg 1998; 228: 627-34.
50. Bismuth H, Majno P, Castaing D, Azoulay D. Intraoperative ultrasonography in liver resection and transplantation. In: Blumgart LH, Fong J, editors. Surgery of the liver and biliary tract, 3rd edn. Edinburgh: Churchill-Livingstone, in press.
51. Nagorney DM, Van Herdeen JA, Ilstrup DM, Anderson MA. Primary hepatic malignancies. Surgical managements and determinants of survival. Surgery 1989; 106: 740-9.
52. Makuuchi M, Takayama T, Gunvèn P, Kosuge T, Yamazaki S, Hasegawa H. Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg 1989; 13: 644-8.
53. Man K, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 1997; 226: 704-13.
54. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F, et al. Continuous versus intermittent portal triad clamping for liver resection. Ann Surg 1999; 229: 369-75.
55. Van Wagensweld BA, van Gulik TM, Gelderblom HC, Sheepers JJG, Bosma A, Endert E, et al. Prolonged continuous or intermittent vascular inflow occlusion during hemihepatectomy in pigs. Ann Surg 1999; 229: 376-84.
56. Bismuth H, Castaing D, Garden OJ. Major hepatic resection under total vascular exclusion. Ann Surg 1989; 210: 13-9.
57. Huguet C, Gavelli A, Bona. Hepatic resection with ischemia of the liver exceeding one hour.J Am Coll Surg 1994; 178: 454-8.
58. Yamaoka Y, Ozawa K, Kumada K, Shimahara Y, Tanaka K, Mori K, et al. Total vascular exclusion for hepatic resection in cirrhotic patients. Application of venovenous bypass. Arch Surg 1992; 127: 276-80.
59. Pichlmayr R, Grosse H, Hauss J, Gubernatis G, Lamesch P, Bretschneider HJ. Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the In situ perfused liver. Br J Surg 1990; 77: 21-6.
60. Delriviere L, Hannoun L. In situ and ex situ in vivo procedures for complex major liver resections requiring prolonged hepatic vascular exclusion in normal and diseased livers. J Am Coll Surg 1995; 181: 272-6.
61. Bismuth H, Houssin D, Castaing D. Major and minor segmentectomies "réglées" in liver surgery World J Surg 1982; 6: 10-24.
62. Takasaki K, Kobayashi S, Tanaka S, Saito A, Yamamoto M, Hanyu F. Highly anatomically systematized hepatic resection with Glissonean sheath code transection at the hepatic hilus. Int Surg 1990; 75: 73-7.
63. Bismuth H, Adam R, Mathur S, Sherlock D. Options for elective treatment of portal hypertension in cirrhotic patients in the transplantation era. Am J Surg 1990; 160: 105-10.
64. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996; 111: 1018-22.
65. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T Criteria for safe hepatic resection. Am J Surg 1995; 169: 589.
66. Fan ST, Lo CM, Lai EC, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med, 1994; 331: 1547-52.
67. Stone MD, Benoti PN: Liver resection: Preoperative and post-operative care. Surg Clin North Am, 1989; 69: 383-92.
68. The San-in Group of Liver Surgery. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. Br J Surg 1997; 84: 1525-31.
69. Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 1995; 21: 1317-21.
70. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986; 10: 803-8.
71. Azoulay D, Raccuia JS, Castaing D, Bismuth H. Right portal vein embolization in preparation for major hepatic resection. J Am Coll Surg 1995; 181: 266-9.
72. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa SI, et al. Preoperative portal vein embolisation: an audit of 84 patients. Hepatology 1999; 29: 1099-105.
73. Gandhi CR, Kuddus R, Subbotin VM, Prelich J, Murase N, Rao AS, et al. A fresh look at augmenter of liver regeneration in rats. Hepatology 1999; 29: 1435-45.
74. Starkell P, Horsmans Y, Sempoux C, De Saeger C, Wary J, Lause P, et al. After portal branch ligation in rat, nuclear factor kB, Interleukin-6, signal transducers and activators of transcription 3, c-fos, c-myc and c-jun are similarly induced in the ligated and nonligated lobes. Hepatology 1999; 29: 1463-70.
75. Moertel CG. Chemotherapy for colorectal cancer. N Engl J Med 1994; 330: 1136-39.
76. Wils J, Sahmoud T, Sobrero A, Bleiberg H, Ahmedzai S, Blazeby J, et al. Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group. Tumori 1998; 84: 335-47.
77. Rougier P, Van Cutsem E, Bajetta E, Niederle N, Possinger K, Labianca R, et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 1998; 352: 1407-12.
78. Oguro A, Nanri M, Miyamoto Y, Ikoma H, Chimori Y, Yamane E, et al. Complete remission of liver metastasis from rectal cancer following continuous oral administration of tegafur-uracil after intrahepatic arterial single injection of CDDP and 5-FU. Gan To Kagaku Ryoho 1998; 25: 1767-9.
79. Kokudo N, Seki M, Ohta H, Azekura K; Ueno M, Sato T, et al. Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases. Ann Surg Oncol 1998; 5: 706-12.
80. Bertheault-Cvitkovic F, Jami A, Ithzaki M, Brummer PD, Brienza S, Adam R, et al. Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer. J Clin Oncol 1996; 14: 2950-8.
81. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685-93.
82. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 1987; 107: 459-65.
83. Elias D, Lasser D, Rougier P. Frequency, technical aspects, results and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 1995; 180: 213-8.
84. Oldhafer KJ, Lang H, Frerker M, Moreno L, Chavan A, Flemming P, et al. First experience and technical aspects of isolated liver perfusion for extensive liver metastasis. Surgery 1998; 123: 622-31.
85. Ravikumar TS, Kane R, Cady B, Jenkins RL, McDermott W, Onik G, et al. Hepatic cryosurgery with intraoperative ultrasound monitoring for metastatic colon carcinoma. Arch Surg 1987; 122: 403-9.
86. Onik G, Rubinsky B, Zemel R, Weaver L, Diamond D, Cobb C, et al. Ultrasound-guided hepatic cryosurgery in the treatment of colorectal metastatic colon carcinoma. Preliminary results. Cancer 1991; 67: 901-7.
87. Adam R, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 1997; 225: 39-50.
88. Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb 1998; 43: 141-54.
89. Rossi S, Buscarini E, Garbagnati F, Di Stasi M, Quaretti P, Rago M, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. Am J Roentgenol 1998; 170: 1015-22.
90. Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A, et al. Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer: a pilot clinical study. Am J Gastroenterol 1999; 94: 322-7.
91. Schneider-Gadicke E, Riethmuller G. Prevention of manifest metastasis with monoclonal antibodies: a novel approach to immunotherapy of solid tumours. Eur J Cancer 1995; 31A: 1326-30.
92. Robert B, Dorvillius M, Buchegger F, Garambois V, Mani JC, Pugnieres M, et al. Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA). Int J Cancer 1999; 81: 285-91.
93. Cao G, Kuriyama S, Du P, Sakamoto T, Kong X, Masui K, et al. Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer. Gastroenterology 1997; 112: 501-10.
94. Kaneko S, Hallenbeck P, Kotani T, Nakabayashi H, Mc Garritty G, Tamaoki T, et al. Adenovirus mediated gene therapy of hepatocellular carcinoma using cancer specific gene expression. Cancer Res 1995; 55: 5283-7.
95. Mohr L, Schauer JI, Boutin RH, Moradpour D, Wands JR. Targeted gene transfer to hepatocellular carcinoma cells in vitro using a novel monoclonal antibody-based gene delivery system. Hepatology 1999; 29: 82-9.
96. Butler J, Attiyeh FF, Daly JM. Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet 1986; 162: 109-13.
97. Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986; 73: 727-731.
98. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1988; 103: 278-88.
99. Sesto ME, Vogt DP, Hermann RE. Hepatic resection in 128 patients : a 24-year experience. Surgery 1987; 102: 846-51.
100. Nordlinger B, Quilichini MA, Pare R, Hannoun L, Delva E, Huguet C. Hepatic resection for colorectal liver metastases: influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 1987; 205: 256-63.
101. Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal cancer-competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 1990; 16: 360-5.
102. Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994; 116: 703-10.
103. Scheele J, Stangl R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
104. Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F, et al. Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg 1995; 82: 377-81.
105. Fuhrman GM, Curley SA, Hohn DC, Roh MS. Improved survival after resection of colorectal liver metastases. Ann Surg Oncol 1995; 2: 537-41.
106. Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C. Patient selection for hepatic resection of colorectal metastases. Arch Surg 1996; 131: 322-9.
107. Jaeck D, Bachelier P, Guiget M, Boudjema K, Vaillant JC, Balladur P, et al. Long term survival following resection of colorectal hepatic metastases. Association Français de Chirurgie. Br J Surg 1997; 84: 977-80.
108. Rees M, Plant G, Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 1997; 84: 1136-1140.
109. Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997; 132: 505-10.
110. Taylor M, Forster J, Langer B, Taylor BR, Greig PD, Mahut C. A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg 1997; 173: 467-71.
111. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938-46.
112. Elias D, Ducreux M, Rougier P, Sabourin JC, Cavalcanti A, Bonvalot S, et al. What are the real indications for hepatectomies in metastases of colorectal origin? Gastroenterol Clin Biol 1998; 22: 1052-5.
113. Cady B, Jenkins RL, Steele GD Jr, Lewis WD, Stone MD, McDermott WV, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 1998; 227: 566-71.
114. Ringe B, Pichlmayer R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15: 270-85.
115. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection for hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 214: 114-7.
116. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218: 145-51.
117. Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993; 18: 1121-26.
118. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, et al. Incidence of factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 488-94.
119. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, et al. Perioperative blood transfusion promotes recurrence in hepatocellular carcinoma after hepatectomy. Surgery 1994; 115: 303-9.
120. Lai ECS, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 1995; 221: 291-8.
121. Shirabe K, Takenaka K, Taketomi A, Kawahara N, Yamamoto K, Shimada M, et al. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 1996; 77: 1050-5.
122. Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H, et al. Results of 280 liver resections for hepatocellular carcinoma Arch Surg 1996; 131: 71-6.
123. Balsells J, Charco R, Lazaro J, Murio E, Vargas V, Allende E, et al. Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 1996, 83: 758-61.
124. Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, Kin T, et al. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Ann Surg 1996; 224: 591-5.
125. Nagashima I, Hamada C, Naruse K, Osada T, Nagao T, Kawano N, et al. Surgical resection for small hepatocellular carcinoma. Surgery 1996; 119: 40-5.
126. Makuuchi M, Takayama T, Kubota K, Kimura W, Midorikawa Y, Miyagawa S, et al. Hepatic resection for hepatocellular carcinoma. - Japanese experience. Hepato-gastroenterology 1998; 45: 1267-74.
127. Maziotti A, Grazi GL, Cavallari A. Surgical treatment of hepatocellular carcinoma on cirrhosis: a western experience. Hepatogastroenterology 1998; 45: 1281-7.
128. Lise M, Bacchetti S, Da Pian Pnitti D, Pilat PL, Pigato P. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma. Cancer 1998; 82: 1028-36.
129. Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999; 229: 322-330.
130. Pretre R, Mentha G, Huber O, Meyer P, Vogel J, Rohner A. Hepatic trauma: risk factors influencing outcome. Br J Surg 1988; 75: 520-4.
131. Pachter HL, Feliciano DV Complex hepatic injuries. Surg Clin North Am 1996; 76: 763-82.
132. Flanagan FL, Dehdashti F, Ogunbiyi OA, Kodner IJ, Siegel B. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998; 227: 319-23.
133. Hughes K, Pinsky CM, Petrelli NJ, Moffat FL, Patt YZ, Hammershaimb L, et al. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer. Ann Surg 1997; 226: 621-31.
134. Wolff BG, Bolton J, Baum R, Chetanneau A, Pecking A, Serafini AN, et al. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT-Tc), a totally human monoclonal antibody. Patient management benefit from a phase III multicenter study. Dis Colon Rectum 1998; 41: 953-62.
135. Bakalos WE, Young DC, Martin EW. Radioimmunoguided surgery for patients with liver metastases secondary to colorectal cancer. Ann Surg Oncol 1998; 5: 590-4.
136. Shirabe K, Takenaka K, Taketomi A, Kawahara N, Yamamoto K, Shimada M, et al. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 1996; 77: 1050-5.
137. Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and non-cirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med 1999; 131: 174-81.
138. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, et al. Prevention of second primary tumors by an acyclic retinoid, Polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996; 334: 1561-7.
139. Venook A. Can a vitamin prevent hepatocellular carcinoma? Hepatology 1997; 25: 249-50.
140. Fan CY, Pan J, Usuda N, Yelandi AV, Rao MS, Reddy JK. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor-alpha natural ligand metabolism. J Biol Chem 1998; 273: 15639-45.
141. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency and cigarette smoking in hepatitis B carriers. Hepatology 1999; 29: 697-702.
142. Matsuda Y, Ichida T, Matsuzawa J, Sugimura K, Asakura H. p16INK4is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 1999; 116: 394-400.
143. Jiang S, Song MJ, Shin E-C, Lee M-O, Kim SJ, Park JH. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways. Hepatology 1999; 29: 101-10.
144. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224: 509-22.
145. Nordlinger B, Vaillant JC, Guiguet M, Balladur P, Paris F, Bachellier P, et al. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Français de Chirurgie. J Clin Oncol 1994; 12: 1491-6.
146. Fernandez-Trigo V, Shamsa F, and other members of the Repeat Hepatic Resection Registry. Repeat liver resections from colorectal metastasis. In: Sugarbaker P, editor. Hepatobiliary cancer. Boston: Kluwer Academic Publishers; 1994. p. 185-96.
147. Que FG, Nagorney DM Resection of recurrent colorectal metastases to the liver. Br J Surg 1994; 81: 255-8.
148. Neeleman N, Andersson R. Repeated liver resection for recurrent liver cancer. Br J Surg 1996; 83: 893-901.
149. Adam R, Bismuth.H, Castaing D, Waechter F, Navarro F, Abascal A, et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg 1997; 225: 51-60.
150. Tuttle TM, Curley SA, Roh MS. Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol 1997; 4: 125-30.
151. Kin T, Nakajima Y, Kanehiro H, Hisanaga M, Ohyama T, Nishio K, et al. Repeat hepatectomy for recurrent colorectal metastases. World J Surg 1998; 22: 1087-91.
152. Regnard JF, Grunenwald D, Spaggiari L, Girard P, Elias D, Ducreux M, et al. Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Ann Thorac Surg 1998; 66: 214-8
153. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688-701.
154. Bismuth H, Houssin D. Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery 1984; 95: 367-70.
155. Mentha G, Belli D, Berner M, Rouge JC, Bugmann P, Morel P, et al. Monosegmental liver transplantation from an adult to an infant. Transplantation 1996; 62: 1176-8.
156. Pichlmayr R, Ringe B, Gubernatis G, Hauss J, Bunzendahl H. Transplantation einer Spenderleber auf zwei Empfänger (splitting transplantation): eine neue Methode in der Weiterentwicklung der Lebersegment Transplantation. Langenbecks Arch Chir 1988; 373: 127-30.
157. Bismuth H, Morino M, Castaing D, Gillon MC, Descorps Declere A, Saliba F, et al. Emergency orthotopic liver transplantation in two patients using one donor liver. Br J Surg 1989; 76: 722-4.
158. de Ville de Goyet J. Split liver transplantation in Europe 1988 to 1993. Transplantation 1995; 59: 1371-6.
159. Rogiers X, Malago M, Habib N, Knoefel WT, Pothmann W, Burdclski M, et al. In situ splitting of the liver in the heart-beating cadaveric organ donor for transplantation in two recipients. Transplantation 1995; 59: 1081-3.
160. Goss JA, Yersiz H, Shackleton CR, Seu P, Smith CV, Markowitz JS, Farmer DG, et al. In situ splitting of the cadaveric liver for transplantation. Transplantation 1997; 64: 871-7.
161. Gridelli, Colledan M. In situ splitting. Impact on the waiting list in Northern Italy. Clin Transplants 1999, in press.
162. Azoulay D, Astarcioglu I, Bismuth H, Castaing D, Majno P, Adam R, et al. Split-liver transplantation. The Paul Brousse Policy. Ann Surg 1996; 224: 737-46.
163. Rela M, Vougas V, Muiesan P, Vilca-Melendez H, Smyrniotis V, Gibbs P, et al. Split liver transplantation: King's College Hospital experience. Ann Surg 1998; 227: 282-8.
164. Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 1990; 212: 368-75.
165. Yamaoka Y, Washida M, Honda K, Tanaka K, Mori K, Shimahara Y, et al. Liver transplantation using a right lobe graft from a living related donor. Transplantation 1994; 57: 1127-30.
166. Lo CM, Fan ST, Lui CL, Wei WL, Lo RJ, Lai CL, et al. Adult to adult liver transplantation using extended right lobe grafts. Ann Surg 1997 226: 261-270.
167. Gubernatis G, Pichlmayr R, Kemnitz J, Gratz K Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first successful case report. World J Surg 1991; 15: 660-5.
168. Bismuth H, Azoulay D, Samuel D, Reynes M, Grimon G, Majno P, et al. Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience. Ann Surg 1996; 224: 712-24.
169. Chenard-Neu MP, Boudjema K, Bernuau J, Degott C, Belghiti J, Cherqui D, et al. Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure-a multicenter European study. Hepatology 1996; 23: 1119-27.